Related references
Note: Only part of the references are listed.Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion
Mandeep S. Virk et al.
BONE (2011)
Expression Pattern of Receptor Activator of NFκB (RANK) in a Series of Primary Solid Tumors and Related Bone Metastases
Daniele Santini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
Wei Tan et al.
NATURE (2011)
Insights into the cell of origin in breast cancer and breast cancer stem cells
Geoffrey J. Lindeman et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2010)
Physiology and pathophysiology of the RANKL/RANK system
Reiko Hanada et al.
BIOLOGICAL CHEMISTRY (2010)
Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis
Jude Canon et al.
BONE (2010)
Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasise
Pamela M. Holland et al.
CANCER BIOLOGY & THERAPY (2010)
Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression
Atish Mukherjee et al.
FASEB JOURNAL (2010)
Effects of Denosumab in Patients With Bone Metastases With and Without Previous Bisphosphonate Exposure
Jean-Jacques Body et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
Eva Gonzalez-Suarez et al.
NATURE (2010)
Control of mammary stem cell function by steroid hormone signalling
Marie-Liesse Asselin-Labat et al.
NATURE (2010)
Progesterone induces adult mammary stem cell expansion
Purna A. Joshi et al.
NATURE (2010)
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
Daniel Schramek et al.
NATURE (2010)
Molecular therapy of breast cancer: progress and future directions
Sheng-Xiang Lin et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland
Manfred Beleut et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Emad A. Rakha et al.
CLINICAL CANCER RESEARCH (2009)
The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse
Rodrigo Fernandez-Valdivia et al.
DEVELOPMENTAL BIOLOGY (2009)
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis
Jane E. Visvader
GENES & DEVELOPMENT (2009)
Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
Karim Fizazi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas
Shuji Mikami et al.
JOURNAL OF PATHOLOGY (2009)
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Andreas Leibbrandt et al.
YEAR IN IMMUNOLOGY 2008 (2008)
Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate
Howard Kendrick et al.
BMC GENOMICS (2008)
Transcriptional Response of the Murine Mammary Gland to Acute Progesterone Exposure
Rodrigo Fernandez-Valdivia et al.
ENDOCRINOLOGY (2008)
RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
Robert E. Miller et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Jun-Li Luo et al.
NATURE (2007)
RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini
Eva Gonzalez-Suarez et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland
Katherine E. Sleeman et al.
JOURNAL OF CELL BIOLOGY (2007)
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation
Gaoping Chen et al.
CANCER (2006)
Regulation of cancer cell migration and bone metastasis by RANKL
DH Jones et al.
NATURE (2006)
Generation of a functional mammary gland from a single stem cell
M Shackleton et al.
NATURE (2006)
RANKL-RANK signaling in osteoclastogenesis and bone disease
T Wada et al.
TRENDS IN MOLECULAR MEDICINE (2006)
CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells
KE Sleeman et al.
BREAST CANCER RESEARCH (2006)
Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength
PJ Kostenuik
CURRENT OPINION IN PHARMACOLOGY (2005)
Survival of mammary stem cells in suspension culture: Implications for stem cell biology and neoplasia
G Dontu et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2005)
Mitogen-activated protein kinases in apoptosis regulation
T Wada et al.
ONCOGENE (2004)
Receptor activator of NF-κB ligand induction via Jak2 and Stat5a in mammary epithelial cells
S Srivastava et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform
B Mulac-Jericevic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial
RT Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function
AP Armstrong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development
YX Cao et al.
CELL (2001)
Mammalian MAP kinase signalling cascades
LF Chang et al.
NATURE (2001)
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
JE Fata et al.
CELL (2000)
Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand:: Modulation of the expression by osteotropic factors and cytokines
T Nakashima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
The PI3K-PDK1 connection: more than just a road to PKB
B Vanhaesebroeck et al.
BIOCHEMICAL JOURNAL (2000)
Share Paper
